News Releases and Announcements

Enter a Year (YYYY)
USP statement on mifepristone approval oral argument before the Supreme Court
March 28, 2024
Expert Committee to vote on final chapter for endotoxin testing using non-animal derived reagents this summer
March 26, 2024
USP, ACS-CAN and Leading Health Advocacy Groups Call on Capitol Hill to End Drug Shortages
March 19, 2024
US Pharmacopeia Signs Memorandum of Understanding with Indian Government
March 14, 2024
USAID Announces Technology Transfer of Novel Process to Produce Active Pharmaceutical Ingredient for Key TB Medicine, Lowering Its Cost and Increasing Availability
March 14, 2024
USP Statement on Third Party Laboratory Benzene Findings 
March 8, 2024
Alliance for Building Better Medicine will receive one of the first-ever NSF Regional Innovation Engines (NSF Engines) Development Awards
March 6, 2024
USP Names Girish Kapur Senior Vice President to Lead India Site Operations
February 22, 2024
USP Medicine Supply Map Impact Analysis: Aurobindo partially halts production at Eugia's Unit-III
February 21, 2024
USP and APIIC announce strategic collaboration to pave the way for a resilient and economically sustainable supply of critical medicines
February 13, 2024
USP Medicine Supply Map Analysis of Impact of Intas Import Alert on Drug Availability
December 19, 2023
ATCC and USP Launch First Set of Products to Advance Quality and Reduce Risk in the Development of Biological Therapeutics and Vaccines
October 30, 2023
JP and USP Prepare a Pilot Program to Promote Harmonization of Pharmacopoeial Standards of Drug Substances and Drug Products
October 25, 2023
Pharmacopoeial Discussion Group welcomes Indian Pharmacopoeia Commission as a member, facilitating reach and enhancing impact of pharmacopoeial standards harmonisation
October 5, 2023
USP Welcomes Executive Delegation from the South African Health Products Regulatory Authority
August 31, 2023
Expert Committee Proposes Chapter for Endotoxin Testing Using Non-Animal Derived Reagents
August 22, 2023
Donated laboratory equipment to help Ghana protect patients from poor-quality medicines
July 24, 2023
U.S. Pharmacopeia statement on supply chain impact of tornado damage to Pfizer Inc. Rocky Mount facility
July 21, 2023
Pharmaceutical Continuous Manufacturing: Knowledge Center Debuts to Expand Information Access, Facilitate Innovation, and Address Barriers to PCM Adoption
July 11, 2023
USP and Africa CDC Launch MOU to Advance Regional Manufacturing and Strengthen Regulatory and Laboratory Systems in Africa
June 29, 2023
Nigeria Pharmaceutical Company First to Receive WHO Prequalification in West Africa
June 6, 2023
Pharmatech Associates’ Board of Directors Appoints Sireesha Yadlapalli as Chief Executive Officer
June 5, 2023
USP and FDA Lead Effort to Bolster Resilience of Global Medicines Supply Chain During APEC United States Host Year
April 25, 2023
U.S. Pharmacopeia Issues Statement on the Decision to Suspend FDA Approval of Mifepristone in the Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration Case
April 10, 2023
COVID-19 Public Health Emergency Ends in the U.S., but Need to Ensure Access to Quality Assured Vaccines Remains
April 4, 2023